Your session is about to expire
← Back to Search
Atherectomy Catheter
Treatment Cohort for Peripheral Arterial Disease (INSIGHT Trial)
N/A
Waitlist Available
Led By Sean Janzer, MD
Research Sponsored by Avinger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post treatment procedure
Awards & highlights
Summary
This trial will test a new treatment for blocked arteries in the legs. The goal is to see if it is safe and effective.
Eligible Conditions
- Peripheral Arterial Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months post treatment procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post treatment procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Freedom from a composite of major adverse events (MAEs) through 30-day follow-up (safety)
Technical success of Pantheris catheter treatment (efficacy) device
Secondary outcome measures
Secondary Effectiveness Endpoint - Ankle-Brachial Index
Secondary Effectiveness Endpoint - Freedom from TLR
Secondary Effectiveness Endpoint - Procedural Success
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Treatment CohortExperimental Treatment1 Intervention
Atherectomy of in-stent restenosis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Atherectomy Catheter
2014
N/A
~180
Find a Location
Who is running the clinical trial?
Avinger, Inc.Lead Sponsor
7 Previous Clinical Trials
426 Total Patients Enrolled
5 Trials studying Peripheral Arterial Disease
322 Patients Enrolled for Peripheral Arterial Disease
Sean Janzer, MDPrincipal InvestigatorEinstein Medical Center
Share this study with friends
Copy Link
Messenger